Brind.

Entities / Company

Juno Therapeutics.

biopharmaceutical company

Seen in 4 reportsLast reported Sep 4

Reports this week: 0
Active events: 0
Connections: 10

What's happening

Reports per dayLast 90 days

90 days agoDrag either end to show only events that began in that periodToday

Earlier this month

FDA is currently reviewing cell therapy products like Breyanzi®, seeking approval for CAR-T cell therapies, but noted insufficient information to establish a link.

Some support1 report

Around Juno Therapeutics this week

News at the entities that move Juno Therapeutics most

FDA Structural
Generic medicine services are seeking approval for launch from the FDA.

Moves Juno Therapeutics
Mon 17:49
Meta Operational
Meta is launching a new commercial wing specifically focused on AI deployment.

Moves Juno Therapeutics
Mon 17:55

Connections

The 2 strongest of 10, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.

Meta Operational

Juno Therapeutics and Meta compete in the advanced cell therapies market.

Some supportJun 2

Juno Therapeutics → Meta
Meta → Juno Therapeutics
FDA Structural

FDA serves as the necessary regulatory body for cell therapy products developed by Juno Therapeutics.

Some supportSep 4

Juno Therapeutics → FDA
FDA → Juno Therapeutics

History

Events by the month they began

September 2026

1 event

Sep 4, 2026FDA is currently reviewing cell therapy products like Breyanzi®, seeking approval for CAR-T cell therapies, but noted insufficient information to establish a link.